CUSIP No. 91818X108 |
13D |
Page 1 of 14 |
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE
13D
Under the Securities Exchange Act of 1934
(Amendment No. 7)*
Uxin Limited |
(Name of Issuer) |
|
Class A
ordinary shares, par value $0.0001 per share |
(Title of Class of Securities) |
|
91818X108** |
(CUSIP Number) |
|
Ning Zhang
Morgan, Lewis & Bockius, LLP
Beijing Kerry Centre South Tower, Suite 823
No. 1 Guang Hua Road, Chaoyang District,
Beijing 100020, China
|
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications) |
|
June 30,
2023 |
(Date of Event which Requires Filing of this Statement) |
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or
240.13d-1(g), check the following box. ¨
* The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
** This CUSIP number pertains to the Issuer’s American Depositary
Shares, each representing thirty Class A Ordinary Shares.
The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 91818X108 |
13D |
Page 2 of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Astral Success Limited |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
2 |
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
BVI |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
754,532,6661 |
8 |
shared voting power |
|
9 |
sole dispositive power |
754,532,666 |
10 |
shared dispositive power |
|
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49%2 |
14 |
type of reporting person* |
CO |
*SEE INSTRUCTION BEFORE FILLING OUT
1 Represents 754,532,666 Class A
Ordinary Shares of the Issuer that may be acquired upon conversion of 437,286,192 Senior Convertible Preferred Shares issued or
issuable to Astral pursuant to the Subscription Agreement and upon exercise of the Warrant held by Astral, which is the sum of (i)
535,714,286 Class A Ordinary Shares that may be acquired upon conversion of 218,467,812 Senior Convertible Preferred Shares held by
Astral reflecting the Anti-dilution Adjustment (as described in Item 2 in the Initial Statements), and (ii) up to 218,818,380 Class A Ordinary
Shares that may be acquired upon conversion of up to 218,818,380 Senior Convertible Preferred Shares that may be acquired upon
exercise of the Warrant held by Astral.
2 The calculation assumes that there
is a total of 2,126,060,462 Class A Ordinary Shares outstanding, which is the sum of the (i) 1,371,527,796 Class A Ordinary Shares outstanding
(including 1,418,902 Class A Ordinary Shares issued to the Issuer’s depositary bank for bulk issuance of ADSs reserved for future
issuances upon the exercise or vesting of awards granted under the Issuer’s share incentive plan), and (ii) 754,532,666 Class A
Ordinary Shares that may be acquired upon conversion of 437,286,192 Senior Convertible Preferred Shares issued or issuable to Astral
pursuant to the Subscription Agreement and upon exercise of the Warrant held by Astral.
CUSIP No. 91818X108 |
13D |
Page 3 of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Joy Capital Opportunity, L.P. |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
2 |
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
Cayman Islands |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
|
8 |
shared voting power |
754,532,666 |
9 |
sole dispositive power |
|
10 |
shared dispositive power |
754,532,666 |
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49% |
14 |
type of reporting person* |
PN |
*SEE INSTRUCTION BEFORE
FILLING OUT
CUSIP
No. 91818X108 |
13D |
Page 4
of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Joy
Capital Opportunity GP, L.P. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
|
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR
2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
Cayman Islands |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
|
8 |
shared voting power |
754,532,666 |
9 |
sole dispositive power |
|
10 |
shared dispositive power |
754,532,666 |
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49% |
14 |
type of reporting person* |
PN |
*SEE INSTRUCTION BEFORE FILLING OUT
CUSIP
No. 91818X108 |
13D |
Page 5
of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Joy Capital II, L.P. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
|
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR
2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
Cayman Islands |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
|
8 |
shared voting power |
754,532,666 |
9 |
sole dispositive power |
|
10 |
shared dispositive power |
754,532,666 |
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49% |
14 |
type of reporting person* |
PN |
*SEE INSTRUCTION BEFORE FILLING OUT
CUSIP
No. 91818X108 |
13D |
Page 6
of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Joy
Capital II GP, L.P. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
|
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR
2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
Cayman Islands |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
|
8 |
shared voting power |
754,532,666 |
9 |
sole dispositive power |
|
10 |
shared dispositive power |
754,532,666 |
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49% |
14 |
type of reporting person* |
PN |
*SEE INSTRUCTION BEFORE FILLING OUT
CUSIP
No. 91818X108 |
13D |
Page 7
of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Joy Capital III, L.P. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
|
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR
2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
Cayman Islands |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
|
8 |
shared voting power |
754,532,666 |
9 |
sole dispositive power |
|
10 |
shared dispositive power |
754,532,666 |
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49% |
14 |
type of reporting person* |
PN |
*SEE INSTRUCTION BEFORE FILLING OUT
CUSIP
No. 91818X108 |
13D |
Page 8
of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Joy Capital III GP, L.P. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
|
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR
2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
Cayman Islands |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
|
8 |
shared voting power |
754,532,666 |
9 |
sole dispositive power |
|
10 |
shared dispositive power |
754,532,666 |
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49% |
14 |
type of reporting person* |
PN |
*SEE INSTRUCTION BEFORE FILLING OUT
CUSIP
No. 91818X108 |
13D |
Page 9
of 14 |
1 |
NameS of Reporting PersonS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) |
Joy Capital GP, Ltd. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
|
|
(a) |
¨ |
|
|
(b) |
¨ |
3 |
SEC USE ONLY |
|
4 |
SOURCE OF FUNDS* (See Instructions) |
OO |
5 |
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR
2(e) |
|
¨ |
|
|
|
6 |
citizenship or place of organization |
Cayman Islands |
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
7 |
sole voting power |
|
8 |
shared voting power |
754,532,666 |
9 |
sole dispositive power |
|
10 |
shared dispositive power |
754,532,666 |
11 |
aggregate amount beneficially owned by each reporting person |
754,532,666 |
12 |
check if the aggregate amount in row (11) excludes certain shares (See INstructions)* |
|
¨ |
|
|
|
13 |
percent of class represented by amount in row (11) |
35.49% |
14 |
type of reporting person* |
OO |
*SEE INSTRUCTION BEFORE FILLING OUT
CUSIP
No. 91818X108 |
13D |
Page 10
of 14 |
| Item 1. | Security and Issuer |
This
Amendment No. 7 to the statement on Schedule 13D (this “Amendment”) relates to the Class A ordinary shares,
par value US$0.0001 per share (the “Class A Ordinary Shares”), of Uxin Limited, a company organized under the
laws of the Cayman Islands (the “Issuer”), whose principal executive offices are located at 1-3/F, No. 12 Beitucheng
East Road, Chaoyang District, Beijing 100029, the People’s Republic of China.
This
Amendment supplements and amends the statement on Schedule 13D, Schedule 13D Amendment No. 1, Schedule 13D Amendment No. 2,
Schedule 13D Amendment No. 3, Schedule 13D Amendment No. 4, Schedule 13D Amendment No. 5 and Schedule 13D Amendment
No. 6 filed on July 22, 2021, November 16, 2021, January 26, 2022, March 29, 2022, July 5, 2022, August 2,
2022 and January 19, 2023 respectively (as amended, the “Initial Statements”). Capitalized terms used in this
Amendment, but not otherwise defined, have the meanings given to them in the Initial Statements.
Other than as amended by this
Amendment, the disclosures in the Initial Statements are unchanged. Responses to each item of this Amendment are incorporated by reference
into the responses to each other item, as applicable.
| Item 2. | Identity and Background |
(a) Name of Person Filing
Item
2(a) of the Initial Statements is hereby amended and supplemented by adding the following before the last paragraph thereof:
The Class A Ordinary Shares reported as beneficially
owned by Astral herein that may be acquired upon conversion of Senior Convertible Preferred Shares that may be acquired upon exercise
of the Warrant are reduced to 218,818,380 Class A Ordinary Shares and the conversion price thereof is adjusted to US$0.0457 per share, as a result of the assignment by Astral to Alpha Wealth Global Limited (“Alpha”) its rights to purchase certain Senior
Convertible Preferred Shares under the Warrant on June 30, 2023 (see discussion in Item 6 below) and the entering into the Warrant
Agreement (as defined below; see discussion in Item 4 below).
Item 4. Purpose of Transaction
Item 4 of the Initial Statements is hereby amended
and supplemented by adding the following before the last paragraph thereof:
The
Issuer, Astral and Alpha entered into an Agreement in Relation to Amendment to and Exercise of Warrants Issued by Uxin Limited on June 30,
2023 (the “Warrant Agreement”), pursuant to which, the exercise price for the Warrant held by Astral with respect
to 218,818,380 Senior Convertible Preferred Shares (the “Warrant Shares”) is amended to US$0.0457 per share, and Astral
agreed to exercise its Warrant to subscribe for the Warrant Shares for an aggregate purchase price of US$10,000,000 by September 30,
2023, subject to the terms and conditions thereof, including customary conditions precedent (which include no material adverse effect
and obtaining of investment committee approval). The Warrant Agreement with respect to Astral may be terminated if Astral has not exercised
the Warrant held by it by September 30, 2023. Upon the termination of the Warrant Agreement between the Company and Astral, the
amendments to the Warrant held by Astral (including exercise price adjustment to US$0.0457 per share) shall be unwound and the terms
of such Warrant shall restore to those existing prior to the amendments.
CUSIP
No. 91818X108 |
13D |
Page 11
of 14 |
The
Warrant Shares, once acquired by Astral pursuant to the Warrant Agreement, are convertible into 218,818,380 Class A Ordinary
Shares at the option of Astral. If the consummation of the purchase and sale of the Senior Convertible Preferred Shares by Astral and/or
Alpha under the Warrant Agreement (the “Warrant Closing”) occurs, it shall constitute a Dilutive Issuance under the
Certificate of Designation in view of the lower issuance price of the Senior Convertible Preferred Shares than the current conversion
price of the Senior Convertible Preferred Shares issued pursuant to the Subscription Agreement. Therefore, if the Warrant Closing occurs,
the conversion price of each Senior Convertible Preferred Share outstanding immediately prior to the Warrant Closing held by Astral and
any other investors (including all Senior Convertible Preferred Shares issued to Astral and any other investors pursuant to the Subscription
Agreement and in the 2022 Transaction) will be reduced and adjusted to US$0.0457 per share in accordance with the anti-dilution clause
specified in the Certificate of Designation.
| Item 5. | Interest in Securities of the Issuer |
Item 5 (a-b) of the Initial Statements is hereby
amended and restated with the following:
(a-b) The
information in the cover pages of this Schedule 13D is incorporated by reference. The calculation of percentage ownership of the
outstanding Class A Ordinary Shares is made pursuant to the requirements of Rule 13d-3(d)(1)(i) under the Exchange Act,
which requires the assumption that Astral, but only Astral, has converted its Senior Convertible Preferred Shares and exercised its Warrant
and assumes that there is currently a total of 1,371,527,796 Class A Ordinary Shares outstanding (including 1,418,902 Class A
Ordinary Shares issued to the Issuer’s depositary bank for bulk issuance of ADSs reserved for future issuances upon the exercise
or vesting of awards granted under the Issuer’s share incentive plan).
The Reporting Persons’ beneficial ownership
of the Class A Ordinary Shares reported as beneficially owned herein includes (i) 535,714,286 Class A Ordinary Shares that
may be acquired upon conversion of 218,467,812 Senior Convertible Preferred Shares held of record by Astral and acquired pursuant to the
Subscription Agreement at a conversion price of US$0.14 per share reflecting the Anti-dilution Adjustment (as defined in the Initial Statements),
and (ii) 218,818,380 Class A Ordinary Shares that may be acquired upon conversion of 218,818,380 Senior Convertible Preferred
Shares that may be acquired upon exercise of the Warrant held by Astral. The reported beneficial ownership does not reflect any anti-dilution
adjustments to the outstanding Senior Convertible Preferred Shares which may be triggered upon the Warrant Closing (as described in Item
4 above).
| Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer |
Item 6 of the Initial Statements is hereby amended and supplemented
by adding the following to the end under the heading “Warrant”:
CUSIP
No. 91818X108 |
13D |
Page 12
of 14 |
Warrant
On June 30, 2023, Astral assigned and transferred
to Alpha the right to purchase 21,496,213 Senior Convertible Preferred Shares under the Warrant held by it. After such assignment,
the right of Astral to purchase Senior Convertible Preferred Shares under the Warrant was reduced from 240,314,593 to 218,818,380.
On June 30, 2023, the Issuer, Astral
and Alpha entered into an Agreement in Relation to the Amendment to and Exercise of Warrants Issued by Uxin Limited, pursuant to
which the exercise price of the Warrant Shares is amended to US$0.0457 per share, and Astral shall exercise its Warrant to purchase
218,818,380 Senior Convertible Preferred Shares for an aggregate amount of US$10,000,000 by September 30, 2023, subject to the
terms and conditions thereof.
| Item 7. | Material to Be Filed as Exhibits |
CUSIP
No. 91818X108 |
13D |
Page 13
of 14 |
SIGNATURE
After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: July 7, 2023
|
Joy
Capital Opportunity, L.P. |
|
|
|
By:
Joy Capital Opportunity GP, L.P. |
|
Its:
general partner |
|
|
|
By:
Joy Capital GP, Ltd. |
|
Its:
general partner |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
|
|
|
Joy
Capital Opportunity GP, L.P. |
|
|
|
By:
Joy Capital GP, Ltd. |
|
Its:
general partner |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
|
|
|
Joy
Capital II, L.P. |
|
|
|
By:
Joy Capital II GP, L.P. |
|
Its:
general partner |
|
|
|
By:
Joy Capital GP, Ltd. |
|
Its:
general partner |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
|
|
|
Joy
Capital II GP, L.P. |
|
|
|
By:
Joy Capital GP, Ltd. |
|
Its:
general partner |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
CUSIP
No. 91818X108 |
13D |
Page 14
of 14 |
|
Joy
Capital III, L.P. |
|
|
|
By:
Joy Capital III GP, L.P. |
|
Its:
general partner |
|
|
|
By:
Joy Capital GP, Ltd. |
|
Its:
general partner |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
|
|
|
Joy
Capital III GP, L.P. |
|
|
|
By:
Joy Capital GP, Ltd. |
|
Its:
general partner |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
|
|
|
Joy
Capital GP, Ltd. |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
|
|
|
Astral
Success Limited |
|
|
|
By: |
/s/ Erhai Liu |
|
|
Erhai Liu, Director |
Attention: Intentional misstatements or omissions
of fact constitute Federal criminal violations
(See 18 U.S.C. 1001)
EXHIBIT 1
Execution
Version
SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN
REDACTED BECAUSE THEY ARE BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. THE REDACTED
TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH THREE ASTERISKS [***].
AGREEMENT IN RELATION TO
AMENDMENT TO AND EXERCISE OF WARRANTS
ISSUED BY UXIN LIMITED
THIS AGREEMENT IN RELATION TO AMENDMENT TO AND
EXERCISE OF WARRANTS ISSUED BY UXIN LIMITED (the “Agreement”) is made and entered into on June 30, 2023 by and
among:
| (1) | Uxin Limited, a company incorporated under the laws of Cayman Islands (the “Company”); |
| (2) | Astral Success Limited, a company incorporated under the laws of the British Virgin Islands (“Astral
Success”); and |
| (3) | Alpha Wealth Global Limited, a company incorporated under the laws of the British Virgin Islands
(“Alpha”, together with Astral Success, the “Purchasers”, and each a “Purchaser”). |
The parties above shall be referred to herein
collectively as the “Parties”, and each as a “Party”.
RECITALS
WHEREAS,
pursuant to a share subscription agreement dated June 14, 2021 by and among Astral Success, Abundant Grace and the Company (as amended
and supplemented from time to time, the “Share Subscription Agreement”), the Company issued a warrant to Astral Success
on July 12, 2021, pursuant to which, Astral Success was entitled to purchase up to 240,314,593 Senior Preferred Shares at the exercise
price of US$0.3433 per share on or prior to 5 p.m. (New York City time) of January 12, 2023, and such exercise period was extended
to 5 p.m. (New York City time) of January 12, 2024 by an amendment agreement dated January 12, 2023 (as may be supplemented,
amended or restated from time to time, the “Joy Warrant”).
WHEREAS,
pursuant to the Share Subscription Agreement, the Company issued a warrant to Abundant Grace Investment Limited (“Abundant Grace”)
on July 12, 2021, pursuant to which, Abundant Grace was entitled to purchase up to 240,314,593 Senior Preferred Shares at the exercise
price of US$0.3433 per share on or prior to 5 p.m. (New York City time) of January 12, 2023. On November 15, 2021, Abundant
Grace assigned part of the foregoing warrant to Abundant Glory Investment L.P. (“Abundant Glory”), and accordingly,
(i) the Company issued a new warrant dated November 15, 2021 (which replaced the foregoing warrant) to Abundant Grace, pursuant
to which, Abundant Grace was entitled to purchase up to 208,272,647 Senior Preferred Shares at the exercise price of US$0.3433 per share
on or prior to 5 p.m. (New York City time) of January 12, 2023, and such exercise period was extended to 5 p.m. (New York
City time) of January 12, 2024 by an amendment agreement dated January 12, 2023 (as may be supplemented, amended or restated
from time to time, the “NIO Grace Warrant”); and (ii) the Company issued a warrant dated November 15, 2021
to Abundant Glory, pursuant to which, Abundant Glory was entitled to purchase up to 32,041,946 Senior Preferred Shares at the exercise
price of US$0.3433 per share on or prior to 5 p.m. (New York City time) of January 12, 2023, and such exercise period was extended
to 5 p.m. (New York City time) of January 12, 2024 by an amendment agreement dated January 12, 2023 (as may be supplemented,
amended or restated from time to time, the “NIO Glory Warrant”).
WHEREAS,
prior to entering into this Agreement and on June 30, 2023, Abundant Grace transferred the NIO Grace Warrant to Alpha, Abundant Glory
transferred the NIO Glory Warrant to Alpha, and Astral Success transferred the right to purchase a part of the Warrant Shares under the
Joy Warrant to Alpha, and as a result, (i) Alpha is entitled to purchase up to 261,810,806 Senior Preferred Shares pursuant to the
terms and conditions of the NIO Grace Warrant, the NIO Glory Warrant and the Joy Warrant (such warrant as assigned to and assumed by Alpha,
the “Alpha Warrant”, together with the Joy Warrant as so reduced, the “Warrants”); and (ii) the
Warrant Shares exercisable by Astral Success under the Joy Warrant is reduced to 218,818,380 Senior Preferred Shares.
NOW,
THEREFORE, in consideration of the premises set forth above, the mutual promises and covenants set forth herein and other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, and intending to be legally bound
hereby, the Parties hereby agree as follows:
Section 1
INTERPRETATION
1.1 Definitions.
Except as otherwise expressly provided herein, capitalized terms used in this Agreement shall have the meanings given in the Warrants,
and the following expressions shall have the following meanings:
“Abundant
Glory” has the meaning ascribed to it in the recitals.
“Abundant
Grace” has the meaning ascribed to it in the recitals.
“Action”
means claim, complaint, action, arbitration, charge, hearing, inquiry, litigation, suit, inquiry, notice of violation, audit, examination,
investigation or any other proceeding or any settlement, judgment, order, award, injunction or decree pending or other proceeding (whether
civil, criminal, administrative, investigative or informal), including, without limitation, an informal investigation or partial proceeding,
such as a deposition.
“ADS” means
the American Depositary Shares of the Company, each representing thirty (30) Class A Ordinary Shares.
“Amendment”
has the meaning ascribed to it in Section 2.1.
“Affiliate”
means with respect to a Person, any other Person that, directly or indirectly, through one or more intermediaries, Controls, is Controlled
by, or is under common Control with, such Person. In the case of any individual, his spouse, child, brother, sister, parent, the relatives
of such spouse, trustee of any trust in which such individual or any of his immediate family members is a beneficiary or a discretionary
object, or any entity or company Controlled by any of the aforesaid Persons. In the case of each Purchaser, the term “Affiliate”
also includes (v) any shareholder of such Purchaser, (w) any of such shareholder’s or such Purchaser’s general partners
or limited partners, (x) the fund manager managing or advising such shareholder or such Purchaser (and general partners, limited
partners and officers thereof) and other funds managed or advised by such fund manager, and (y) trusts controlled by or for the benefit
of any such Person referred to in (v), (w) or (x), and (z) any fund or holding company formed for investment purposes that is
promoted, sponsored, managed, advised or serviced by such Purchaser. For purposes of this Agreement, no Purchaser shall be deemed
an Affiliate of the Company.
“Agreement”
has the meaning ascribed to it in the preamble.
“Alpha”
has the meaning ascribed to it in the preamble.
“Alpha
Warrant” has the meaning ascribed to it in the recitals.
“Applicable Law(s)”
means, with respect to any Person, any transnational, domestic or foreign federal, national, state, provincial, local or municipal law
(statutory, common or otherwise), constitution, treaty, convention, ordinance, code, rule, regulation, executive order, injunction, judgment,
decree, ruling or other similar requirement enacted, adopted, promulgated or applied by a Governmental Entity that is binding upon or
applicable to such Person or any of such Person’s assets, rights or properties.
“Astral
Success” has the meaning ascribed to it in the preamble.
“Board”
means the board of directors of the Company.
“Business Day”
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking
institutions in the Cayman Islands, the People’s Republic of China (which for the purpose of this Agreement shall exclude Hong Kong
SAR, Macau SAR and Taiwan) or the State of New York are authorized or required by law or other governmental action to close.
“Cap
Amount” has the meaning ascribed to it in Section 10.10.
“Certificate of Designation”
means the Second Amended and Restated Certificate of Designation of Senior Convertible Preferred Shares with respect to the rights and
preferences of the Senior Preferred Shares, in the form attached hereto as Exhibit I, as maybe amended from time to time pursuant
to its terms.
“Closing”
has the meaning ascribed to it in Section 4.1.
“Closing Date”
has the meaning ascribed to it in Section 4.1.
“Class A Ordinary
Shares” means the Company’s class A ordinary shares with par value of US$0.0001 per share.
“Class B Ordinary
Shares” means the Company’s class B ordinary shares with par value of US$0.0001 per share.
“Company”
has the meaning ascribed to it in the preamble.
“Company Fundamental
Representations” has the meaning ascribed to it in Section 8.5.
“Control”
of a given Person means the power or authority, whether exercised or not, to direct the business, management or policies of such Person,
directly or indirectly, whether through the ownership of voting Equity Securities, by contract or otherwise, which power or authority
shall conclusively be presumed to exist upon possession of beneficial ownership or power to direct the vote of more than fifty percent
(50%) of the votes (on an as-converted basis) entitled to be cast at a meeting of the members or shareholders of such Person or power
to control the composition of a majority of the board of directors or similar governing body of such Person; the terms “Controlled”
and “Controlling” shall have the meanings correlative to the foregoing.
“Conversion Shares”
means Class A Ordinary Shares issued or issuable upon conversion of the Senior Preferred Shares.
“Designated Bank
Account” has the meaning ascribed to it in Section 8.2.
“Encumbrance”
means (a) any mortgage, charge, pledge, lien, hypothecation, deed of trust, title retention, title defect, security interest, encumbrance
or other third-party rights of any kind securing or conferring any priority of payment in respect of any obligation of any Person, any
other restriction or limitation; (b) any easement or covenant granting a right of use or occupancy to any Person; (c) any proxy,
power of attorney, voting trust agreement, interest, option, right of first offer, right of pre-emptive negotiation, or refusal or transfer
restriction in favor of any Person; and (d) any adverse claim as to title, possession, or use, and includes any agreement or arrangement
for any of the same.
“Equity
Securities” means, with respect to any Person that is a legal entity, any and all shares of capital stock, membership interests,
units, profits interests, ownership interests, equity interests, registered capital, and other equity securities of such Person, and any
right, warrant, option, call, commitment, conversion privilege, preemptive right or other right to acquire any of the foregoing, or security
convertible into, exchangeable or exercisable for any of the foregoing.
“Exchange Act”
means the U.S. Securities Exchange Act of 1934, as amended, and any rules and regulations promulgated thereunder.
“Governmental Entity”
mean (i) any national, federal, state, county, municipal, local, or foreign government or any entity exercising executive, legislative,
judicial, regulatory, taxing, or administrative functions of or pertaining to government, (ii) any public international organization,
(iii) any agency, division, bureau, department, or other political subdivision of any government, entity or organization described
in the foregoing clauses (i) or (ii) of this definition, (iv) any company, business, enterprise, or other entity owned,
in whole or in part, or Controlled by any government, entity, organization, or other Person described in the foregoing clauses (i), (ii) or
(iii) of this definition, or (v) any political party.
“HKIAC”
has the meaning ascribed to it in Section 10.9.
“Hong
Kong” means the Hong Kong Special Administrative Region of the PRC.
“Indemnified
Party” or “Indemnified Parties” has the meaning ascribed to it in Section 9.1.
“Indemnifying
Party” has the meaning ascribed to it in Section 9.1.
“Joy
Warrant” has the meaning ascribed to it in the recitals.
“Loss”
has the meaning ascribed to it in Section 9.1.
“Loss
Threshold” has the meaning ascribed to it in Section 9.1(b).
“Material
Adverse Effect” means any event, occurrence, fact, condition, change or development, individually or together with other
events, occurrences, facts, conditions, changes or developments, that has had, has, or would reasonably be expected to have a
material adverse effect on (a) the business of the Company as presently conducted, or the condition (financial or otherwise),
affairs, properties, employees, liabilities, assets, results of operation or prospects of the Company and its Subsidiaries taken as
a whole or (b) the ability of the Company to timely consummate the transactions contemplated by this Agreement (including the
sale of the Warrant Shares) or timely perform its material obligations hereunder and thereunder; provided, however,
that in determining whether a Material Adverse Effect has occurred, there shall be excluded any effect on the business of the
Company or the Company or any Subsidiary relating to or arising in connection with (i) any action required to be taken pursuant
to the terms and conditions of this Agreement or taken at the written direction of the Purchasers, (ii) economic changes
affecting the industry in which the Company and its Subsidiaries operate generally or the economy of the PRC or any other market
where the Company and its Subsidiaries have material operations or sales generally (provided in each case that such changes do not
have a unique and materially disproportionate impact on the business of the Company and its Subsidiaries), (iii) the execution,
announcement or disclosure of this Agreement or the pendency or consummation of the transactions contemplated hereunder,
(iv) actions or omissions of the Company and its Subsidiaries that have been consented by the Purchasers in writing,
(v) changes in generally accepted accounting principles that are generally applicable to comparable companies (provided that
such changes do not have a unique and materially disproportionate impact on the business of the Company and its Subsidiaries),
(vi) changes in general legal, tax or regulatory conditions (provided that such changes do not have a unique and materially
disproportionate impact on the business of the Company and its Subsidiaries), (vii) changes in national or international
political or social conditions, including any engagement in hostilities or the occurrence of any military or terrorist attack or
civil unrest in each case occurring after the date hereof, or (viii) earthquakes, hurricanes, floods, epidemic-induced public
health crises or other disasters in each case occurring after the date hereof.
“Nasdaq”
means the NASDAQ Global Select Market.
“NIO
Glory Warrant” has the meaning ascribed to it in the recitals.
“NIO
Grace Warrant” has the meaning ascribed to it in the recitals.
“Ordinary Shares”
means Class A Ordinary Shares and Class B Ordinary Shares.
“Party”
or “Parties” has the meaning ascribed to it in the preamble.
“Permits”
has the meaning ascribed to it in Section 5.7(b).
“Person”
means any natural person, firm, corporation, limited liability company, partnership, joint venture, association, joint-stock company,
trust, unincorporated organization, Governmental Entity or any other legal entity, including public bodies, whether acting in an individual,
fiduciary or other capacity.
“PRC” means
the People’s Republic of China, excluding for the purpose of this Agreement, Hong Kong, the Macau Special Administrative Region
of the People’s Republic of China and Taiwan.
“Principal Holding
Company” means Xin Gao Group Limited, a company organized under the laws of the British Virgin Islands.
“Principal
Parties” means Mr. Kun Dai (戴琨) and the Principal
Holding Company.
“Purchaser”
or “Purchasers” has the meaning ascribed to it in the preamble.
“Registration Rights
Agreement” means the registration rights agreement, in the form attached hereto as Exhibit II, to be entered into
by and among the Company and the Purchasers at the Closing.
“Sarbanes-Oxley Act”
means the U.S. Sarbanes-Oxley Act of 2002, as amended, and any rules and regulations promulgated thereunder.
“SEC” means
the U.S. Securities and Exchange Commission.
“SEC
Documents” has the meaning ascribed to it in Section 5.6.
“Securities Act”
means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Senior Preferred
Shares” means the senior convertible preferred shares of the Company with par value of US$0.0001 per share.
“Share Subscription
Agreement” has the meaning ascribed to it in the recitals.
“Subsidiary”
means any entity of which a majority of the outstanding equity securities or other ownership interests representing a majority of the
outstanding equity interests or otherwise having ordinary voting power to elect a majority of the board of directors or other Persons
performing similar functions are at the time directly or indirectly owned or Controlled by the Company, and includes any entity which
is directly or indirectly Controlled by the Company (including, for the avoidance of doubt, any variable interest entities that are consolidated
into the financial statements of the Company).
“Trading Market”
means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading on the date in question:
the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange (or any
successors to any of the foregoing).
“Transaction Documents”
means this Agreement, the Voting Agreement, the Registration Rights Agreement, the Certificate of Designation and any other documents
or agreements executed on or after the date of this Agreement in connection with the transactions contemplated hereunder.
“USD” or
“US$” means the United States dollars, the lawful currency of the United States of America.
“Voting Agreement”
means the amended and restated voting agreement, in the form attached hereto as Exhibit III, to be entered into by and among
the Company, the Principal Parties, Astral Success, Abundant Grace and Abundant Glory at the Closing.
“Warrants”
has the meaning ascribed to it in the recitals.
“Warrant Shares”
shall have the meaning ascribed to it in Section 3.1.
Section 2
AMENDMENT TO THE WARRANTS
2.1 Amendments.
With effect from the date hereof, each of the Warrants shall be amended in accordance with section 8(a) thereof on the terms set
out below (each an “Amendment”):
(a) Section 1(b) of
the Joy Warrant is hereby deleted in its entirety and replaced with the following:
“Exercise Price.
The exercise price per Share shall be the equivalent of US$0.0457 per Share, subject to adjustment pursuant hereto (the “Exercise
Price”), and the aggregate Exercise Price for all Shares issuable under this Warrant is up to US$10,000,000.”
(b) Section 1(b) of
the Alpha Warrant is hereby deleted in its entirety and replaced with the following:
“Exercise Price.
The exercise price per Share shall be the equivalent of US$0.0457 per Share, subject to adjustment pursuant hereto (the “Exercise
Price”), and the aggregate Exercise Price for all Shares issuable under this Warrant is up to US$11,964,754.”
2.2 Integration.
Each Amendment shall be read together with and as an integral part of the applicable Warrant so that any reference in the applicable Warrant
to “this Warrant” and any reference in the other Transaction Documents to the “Warrant” and similar expressions
shall refer to the related Warrant as amended by the applicable Amendment. Any and all references in the other Transaction Documents to
the “Warrant”, “thereof” and words of like import shall be deemed to refer to the applicable Warrant (as amended
by the applicable Amendment under this Section 2).
2.3 No
Other Amendment.
(a) This
Section 2 shall be limited solely to the matters expressly set forth herein and shall not (i) constitute an amendment
of any other term or condition of the Warrants or (ii) prejudice any right or rights each Purchaser may now have or may have in the
future under or in connection with the applicable Warrant.
(b) Except
to the extent specifically amended herein (including under Section 3), each of the respective provisions of each Warrant shall
not be amended, modified, impaired or otherwise affected hereby, and each Warrant and the obligations thereunder are hereby confirmed
in full force and effect.
(c) The
amendment to the Warrants set forth herein is not a Dilutive Issuance (as defined in the Amended and Restated Certificate of Designation
of Senior Convertible Preferred Shares of the Company) and a Dilutive Issuance shall only occur upon the Closing.
Section 3
EXERCISE OF WARRANTS
3.1 Exercise.
Subject to the terms and conditions hereof, at the Closing (as defined below), each of Astral Success and Alpha shall exercise the Joy
Warrant and the Alpha Warrant in full respectively to purchase that certain number of Senior Preferred Shares (the “Warrant Shares”)
for that certain Exercise Price set forth opposite such Purchaser’s name in Schedule I at a per share exercise price equal
to US$0.0457 (corresponding to US$1.37 per ADS) in an aggregate amount of US$21,964,754.
Section 4
CLOSING
4.1 Closing.
The closing for the sale and purchase of the Warrant Shares shall take place remotely via the exchange of documents and signatures promptly
upon satisfaction or waiver of the conditions set forth in Section 7, at a time agreed by the Company and the Purchasers,
but in no event later than September 30, 2023 unless otherwise extended by the Company and the Purchasers in writing (the “Closing”,
such date when the Closing occurs, the “Closing Date”). For the avoidance of doubt, the Closing for each Purchaser
can occur separately. Failure by any Purchaser to consummate the Closing will not affect the Closing by the other Purchaser.
4.2 Closing
Deliverables. On the Closing Date, the following actions shall take place, all of which shall be deemed to have occurred simultaneously
and no action shall be deemed to have been completed or any document delivered until all such actions have been completed and all required
documents have been delivered:
(a) Each
of the Purchasers shall deliver to the Company the following deliverables:
(i) deliver
to the Company a Notice of Exercise in the form of EXHIBIT A of the Warrants, duly completed and executed by or on behalf of such
Purchaser;
(ii) pay
the applicable Exercise Price in cash by wire transfer of immediately available funds in USD to the Designated Bank Account (as defined
below) as set forth in Schedule II;
(iii) deliver
to the Company the Voting Agreement duly executed by or on behalf of such Purchaser; and
(iv) deliver
to the Company the Registration Rights Agreement duly executed by or on behalf of such Purchaser.
(b) the
Company shall:
(i) allot
and issue to each Purchaser the Warrant Shares being purchased by such Purchaser, and deliver to each Purchaser one or more duly executed
share certificate(s) representing such Warrant Shares registered in the name of related Purchaser (the original copies of which
shall be delivered to each Purchaser as soon as practicable within 10 Business Days following the Closing Date);
(ii) deliver
to each Purchaser a certified true copy of the register of members of the Company evidencing the Warrant Shares being owned by each Purchaser
at the Closing;
(iii) deliver
to Astral Success the Voting Agreement duly executed by or on behalf of the Company, the Principal Parties, Abundant Grace and Abundant
Glory;
(iv) deliver
to each Purchaser the Registration Rights Agreement duly executed by or on behalf of the Company;
(v) deliver
to each Purchaser a copy of (i) the resolutions adopted by the Board approving this Agreement and other Transaction Documents and
matters relating to the Closing, and (ii) the Certificate of Designation in effect at the Closing;
(vi) deliver
to each Purchaser an incumbency certificate in the form attached hereto as Schedule IV;
(vii) deliver
to each Purchaser the certificate referred to in Section 7.1(o); and
(viii) deliver
to each existing holder of Senior Preferred Shares of the Company a Dilutive Issuance Notice (as defined in the Certificate of Designation)
in the form attached hereto as Exhibit IV, duly executed by or on behalf of the Company.
Section 5
REPRESENTATIONS AND WARRANTIES OF THE Company
The Company represents and
warrants to each Purchaser that, except as otherwise disclosed in the SEC Documents, as of the date of this Agreement and as of the Closing
Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date):
5.1 Organization,
Good Standing and Qualification.
(a) The
Company is an exempted company that is duly organized, validly existing and in good standing under the laws of the Cayman Islands, with
the requisite corporate power and authority to carry on its business as currently conducted. The Company has the necessary power and
authority to execute and deliver this Agreement, to carry out its obligations hereunder and to consummate the transactions contemplated
hereby.
(b) Each
Subsidiary is duly incorporated or otherwise organized, validly existing and in good standing under the laws of its jurisdiction of incorporation,
with the requisite corporate power and authority to carry on its business as currently conducted.
5.2 Capitalization.
(a) As
June 29, 2023, the authorized share capital of the Company is US$ 1,000,000 divided into 10,000,000,000 shares comprising of (i) 8,180,000,000
Class A Ordinary Shares, of which 1,370,108,894 Class A Ordinary Shares (excluding the 1,418,902 Class A Ordinary Shares
issued to the Company’s depositary bank for bulk issuance of ADSs reserved for future issuance upon the exercise or vesting of
awards granted under the Company’s share incentive plan) were issued and outstanding, (ii) 100,000,000 Class B Ordinary
Shares, of which 40,809,861 Class B Ordinary Shares were issued and outstanding, and (iii) 1,720,000,000 Senior Preferred Shares,
of which, 436,935,624 Senior Preferred Shares with a stated value equal to US$0.3433 and 714,285,714 Senior Preferred Shares with a stated
value equal to US$0.14 were issued and outstanding. Except as otherwise disclosed in the SEC Documents, all of the outstanding Equity
Securities of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance with all
applicable securities laws, and none of such outstanding shares was issued in violation of any pre-emptive rights, rights of first refusal,
right of participation or similar rights to subscribe for or purchase securities.
(b) Upon
the adoption of the Certificate of Designation by the Board and immediately prior to the Closing, the authorized share capital of the
Company is US$ 1,000,000 divided into 10,000,000,000 shares comprising of (i) 8,180,000,000 Class A Ordinary Shares, (ii) 100,000,000
Class B Ordinary Shares, of which 40,809,861 Class B Ordinary Shares were issued and outstanding, and (iii) 1,720,000,000
Senior Preferred Shares, of which, 436,935,624 Senior Preferred Shares with a stated value equal to US$0.3433 and 714,285,714 Senior
Preferred Shares with a stated value equal to US$0.14 were issued and outstanding, and 480,629,186 Senior Preferred Shares with a stated
value equal to US$0.0457, none of which are issued and outstanding. The Warrant Shares issuable upon the Closing and the Conversion Shares
issuable upon conversion of the Warrant Shares shall be duly and validly reserved for issuance.
(c) When
issued in compliance with the provisions of this Agreement, the Warrant Shares will be (i) validly issued, fully paid and non-assessable,
(ii) issued in compliance with the applicable registration and qualification requirements of Applicable Laws, and (iii) will
be free from all rights of first refusal, pre-emptive or similar rights, taxes and Encumbrances; provided, however, that the Warrant
Shares may be subject to restrictions on transfer under the applicable securities laws.
(d) The
Company has no outstanding bonds, debentures, notes or other obligations, the holders of which have the right to vote (or which are convertible
into or exercisable for securities having the right to vote) with the shareholders of the Company on any matter. There are no outstanding
options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights
or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Equity
Securities of the Company, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may
become bound to issue additional Equity Securities. There are no obligations (whether outstanding or authorized) of the Company or any
Subsidiary requiring the repurchase of any Equity Securities of the Company.
(e) Each
of the Company and its Subsidiaries has good and valid title to its Equity Securities and there are no defects or disputes with respect
to its Equity Securities.
5.3 Non-Contravention.
Neither the execution and the delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will (i) violate
any provision of the memorandum and articles of association or other constitutional documents of the Company or (ii) violate any
constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge, or other restriction of any Governmental
Entity to which the Company is subject, or (iii) conflict with, result in a breach of, constitute a default under, result in the
acceleration of or creation of an Encumbrance under, create in any party the right to accelerate, terminate, modify, or cancel, or require
any notice under, any agreement, contract, lease, license, instrument, or other arrangement to which the Company is a party or by which
the Company is bound or to which any of the Company’s assets are subject, except in the case of clauses (ii) and (iii) as
would not have a Material Adverse Effect. There is no Action, suit or proceeding, pending or, to the knowledge of the Company, threatened
against the Company that questions the validity of this Agreement or the right of the Company to enter into this Agreement to consummate
the transactions contemplated hereby.
5.4 No
Securities Act Registration. Assuming the accuracy of the representations of the Purchasers contained in Section 6.3,
it is not necessary in connection with the issuance and sale to the Purchasers of the Warrant Shares to register the Warrant Shares under
the Securities Act or to qualify or register the Warrant Shares under applicable U.S. state securities laws.
5.5 Consent
and Approvals. Neither the execution and delivery by the Company of this Agreement, nor the consummation by the Company of any of
the transactions contemplated hereby, nor the performance by the Company of this Agreement in accordance with its terms requires the
consent, approval, order or authorization of, or registration or filing with, or the giving notice to, any governmental or public body
or authority or any third party prior to or after the Closing, except for those have been or will have been obtained, made or given on
or prior to the Closing and those filings required to be made with the SEC and Nasdaq (including, without limitation, a Form 6-K).
5.6 Accuracy
of Disclosure. The Company has filed or furnished, as applicable, on a timely basis, all registration statements, proxy statements
and other statements, reports, schedules, forms and other documents required to be filed or furnished by it with the SEC (all of the
foregoing documents filed with or furnished to the SEC and all exhibits included therein and financial statements, notes and schedules
thereto and documents incorporated by reference therein, the “SEC Documents”). As of their respective effective dates
(in the case of the SEC Documents that are registration statements filed pursuant to the requirements of the Securities Act) and as of
their respective SEC filing dates (in the case of all other SEC Documents), or in each case, if amended prior to the date hereof, as
of the date of the last such amendment: (A) each of the SEC Documents complied in all material respects with the applicable requirements
of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act and any rules and regulations promulgated thereunder applicable
to the SEC Documents (as the case may be) and (B) none of the SEC Documents contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. The agreements and documents described in the SEC Documents conform to
the descriptions thereof contained therein and there are no agreements or other documents required by the Securities Act and the rules and
regulations thereunder to be described in the SEC Documents that have not been so filed. Each agreement or other instrument (however
characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is referred
to in the SEC Documents, or (ii) is material to the Company’s business, has been duly authorized and validly executed by the
Company, is in full force and effect in all material respects and is enforceable against the Company in accordance with its terms, except
(x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights
generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities
laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable
defenses and to the discretion of the court before which any proceeding therefore may be brought. Except as described in the SEC Documents,
none of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the best of the Company’s
knowledge, any other party is in default thereunder and, to the best of the Company’s knowledge, no event has occurred that, with
the lapse of time or the giving of notice, or both, would constitute a default thereunder. Performance by the Company of such agreements
or instruments will not result in a material violation of existing Applicable Laws, rules, regulations, judgments, orders or decrees
of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including,
without limitation, those relating to environmental laws and regulations.
5.7 Compliance
with Laws.
(a) Except
as disclosed in the SEC Documents, the Company or its Subsidiaries is and has been since January 1, 2017 in compliance with all
Applicable Laws of any Governmental Entity in all material respects. Since January 1, 2017, except as set forth in the SEC Documents,
neither the Company nor any Subsidiary (i) is or has been in default under or in violation of (and no event has occurred that has
not been waived that, with notice or lapse of time or both, would result in a default), nor has the Company or any Subsidiary received
notice of a claim that it is in default under or is in violation of any indenture, loan or credit agreement or any other agreement or
instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been
waived), (ii) is or has been in violation of any order of any court, arbitrator or any Governmental Entity, or (iii) is or
has been in violation of any Applicable Law of any Governmental Entity, including, without limitation, all Applicable Laws relating to
taxes, environmental protection, occupational health and safety, and employment and labor matters, anti-bribery and anti-money laundering,
in each case in any material respects.
(b) Except
as disclosed in the SEC Documents, the Company and each of its Subsidiaries have all permits, licenses, authorizations, consents, orders
and approvals (collectively, “Permits”), and have made all filings, applications and registrations with, any Governmental
Entity that are required in order to carry on their business as presently conducted in all material respects. Except as disclosed
in the SEC Documents, all such Permits are in full force and effect in all material respects and, to the knowledge of the Company, no
suspension or cancellation of any of them is threatened, and all such filings, applications and registrations are current.
(c) The
Company is not in violation of any listing requirements of any Trading Market and has no knowledge of any facts that would reasonably
be expected to lead to delisting or suspension of its ADSs from the Trading Market in the foreseeable future.
5.8 Listing
and Maintenance Requirements. The Ordinary Shares are registered pursuant to Section 12(b) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the
Ordinary Shares under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating such registration.
Except as set forth in the SEC Documents, the Company has not received notice from any Trading Market on which the ADSs representing
the Ordinary Shares are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Company’s trading in the ADSs has not been suspended
or delisted by the SEC or the Company’s Trading Market, nor, except as set forth in the SEC Documents, has such suspension or delisting
been threatened. The issuance by the Company of the Warrant Shares shall not have the effect of delisting or suspending the ADSs representing
the Ordinary Shares from any Trading Market.
Section 6
REPRESENTATIONS AND WARRANTIES OF THE Purchasers
Each Purchaser severally
but not jointly represents and warrants, with respect to itself, to the Company that, as of the date of this Agreement and as of the
Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date) that:
6.1 Organization,
Good Standing and Qualification. Such Purchaser is duly organized, validly existing and in good standing under the Applicable Laws
of the jurisdiction of its incorporation. Such Purchaser has the necessary power and authority to execute and deliver this Agreement,
to carry out its obligations hereunder and to consummate the transactions contemplated hereby.
6.2 Access
to Fund. Such Purchaser will have on the Closing Date cash available in an amount adequate to pay the Exercise Price payable by it
on the Closing Date pursuant to this Agreement.
6.3 Securities
Law Matters. Such Purchaser acknowledges that the Warrant Shares are characterized as “restricted securities” within
the meaning of Rule 144 under the Securities Act and have not been registered under the Securities Act or any applicable state securities
laws. Such Purchaser further acknowledges that, absent an effective registration under the Securities Act, the Warrant Shares may only
be offered, sold or otherwise transferred under certain circumstances in compliance with Applicable Laws. Such Purchaser is acquiring
the Warrant Shares for its own account without violation of applicable securities laws, provided, that, this representation and warranty
does not obligate such Purchaser to hold any of the Warrant Shares for any minimum or other specific term, nor limit such Purchaser’s
right to sell the Warrant Shares pursuant to an effective registration statement under the Securities Act or otherwise in compliance
with applicable federal and state securities laws. Such Purchaser is a sophisticated investor with knowledge and experience in financial
and business matters such that such Purchaser is capable of evaluating the merits and risks of the
investment in the Warrant Shares. Such Purchaser is able to bear the economic risks of an investment in the Warrant Shares.
6.4 Non-Contravention.
Neither the execution and the delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will (i) violate
any provision of the memorandum and articles of association or other constitutional documents of such Purchaser or (ii) violate
any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge, or other restriction of any Governmental
Entity to which such Purchaser is subject, or (iii) conflict with, result in a breach of, constitute a default under, result in
the acceleration of or creation of an Encumbrance under, create in any party the right to accelerate, terminate, modify, or cancel, or
require any notice under, any agreement, contract, lease, license, instrument, or other arrangement to which such Purchaser is bound
or to which any assets of such Purchaser are subject.
6.5 Consent
and Approvals. Neither the execution and delivery by such Purchaser of this Agreement, nor the consummation by such Purchaser of
any of the transactions contemplated hereby, nor the performance by such Purchaser of this Agreement in accordance with its terms requires
the consent, approval, order or authorization of, or registration with, or the giving notice to, any governmental or public body or authority
or any third party, except such as have been or will have been obtained, made or given on or prior to the Closing.
6.6 No
Additional Representations; Non-reliance. Such Purchaser acknowledges and agrees that, except as expressly set forth in Section 5,
no Person is making or has made any other written or oral representation or warranty, express or implied, of any nature whatsoever, with
respect to the Company or its Subsidiaries or the transactions contemplated hereby, and such Purchaser disclaims that it is relying
on or has relied on any such representation or warranty as an inducement to enter into this Agreement or otherwise.
Section 7
CONDITIONS AT THE CLOSING
7.1 Conditions
to each Purchaser’s Obligations to Fulfill the Closing. The obligations of each Purchaser under this Agreement at the Closing
are subject to the fulfillment, or waiver by each Purchaser, of the following conditions, upon or before the Closing:
(a) no
provision of any Applicable Law shall prohibit the consummation of such Closing;
(b) no
proceeding challenging this Agreement or the Transaction Documents or the transactions contemplated hereby, or seeking to prohibit, alter,
prevent or materially delay the Closing, shall have been instituted before any Governmental Entity and shall be pending;
(c) the
representations and warranties of the Company (other than the Company Fundamental Representations) that are qualified by materiality
or Material Adverse Effect shall be true and correct in all respects on and as of the date hereof and such Closing (except that those
representations and warranties that address matters only as of a particular date shall have been true and correct only on such date);
(d) the
representations and warranties of the Company (other than the Company Fundamental Representations) that are not qualified by materiality
or Material Adverse Effect shall be true and correct in all material respects on and as of the date hereof and such Closing (except that
those representations and warranties that address matters only as of a particular date shall have been true and correct only on such
date);
(e) the
Company Fundamental Representations shall be true and correct in all respects on and as of the date hereof and such Closing except for
de minimis inaccuracies (except that those representations and warranties that address matters only as of a particular date shall have
been true and correct only on such date);
(f) the
Company shall have performed and complied with all of the agreements, obligations and conditions contained in this Agreement that are
required to be performed or complied with by it in all material respects on or before the Closing, including without limitation the delivery
of each of the documents specified in Section 4.2(b);
(g) all
consents of any competent Governmental Entity (not applicable if no approval from any competent Governmental Entity is required) or of
any other Person that are required to be obtained by the Company prior to the Closing in connection with the consummation of the transactions
contemplated by the Transaction Documents shall have been duly obtained and effective as of the Closing;
(h) all
corporate and other proceedings required for transactions contemplated hereby on the Closing and all documents and instruments incidental
to such transactions shall have been duly completed and satisfactory in substance and form to each Purchaser, and each Purchaser
shall have received all such counterpart originals or certified or other copies of such documents as it may reasonably request;
(i) there
shall have been no event, occurrence, development or state of circumstances or facts that constitutes a Material Adverse Effect;
(j) from
the date hereof to the Closing, the Company’s trading in the ADSs shall not have been suspended by the SEC or the Company’s
principal Trading Market (nor shall such suspension have been threatened);
(k) the
sale and issuance of the Warrant Shares shall be legally permitted by all laws and regulations to which the Purchasers and the Company
are subject;
(l) the
Board shall have duly approved and adopted the Certificate of Designation and have approved all necessary matters relating to the Closing
to the satisfaction of each Purchaser;
(m) signature
pages to the Transaction Documents other than those to be signed by each Purchaser shall have been sent to the counsel of the Purchasers
for examination to the reasonable satisfaction of such counsel and to hold in escrow to release upon the Closing;
(n) the
investment committee or internal decision making department of such Purchaser has approved this Agreement and the transactions contemplated
hereunder; and
(o) the
Purchasers shall have received a certificate signed by an executive officer of the Company confirming the satisfaction of items (a) through
(l) above.
7.2 Conditions
to the Company’s Obligations to Fulfill the Closing. The obligations of the Company under this Agreement at the Closing are
subject to the fulfilment, or the waiver by the Company, of the following conditions upon or before the Closing:
(a) no
provision of any Applicable Law shall prohibit the consummation of such Closing;
(b) no
proceeding challenging this Agreement or the Transaction Documents or the transactions contemplated hereby, or seeking to prohibit, alter,
prevent or materially delay the Closing, shall have been instituted before any Governmental Entity and shall be pending;
(c) the
representations and warranties of such Purchaser contained in Section 6 hereof shall be and shall remain to be true and correct
in all material respects on and as of the date hereof and as of the Closing Date, with the same force and effect as if they had been
made on and as of the Closing Date, except for those representations and warranties that address the matters only as of a particular
date, which representations and warranties shall have been true and correct in all material respects as of such particular date; and
(d) such
Purchaser shall have performed and complied with all the agreements, obligations and conditions contained in this Agreement that are
required to be performed or complied with by it in all material respects on or before the Closing.
Section 8
ADDITIONAL AGREEMENTS
8.1 Most
Favoured Nation Treatment. In the event that the Company has granted or grants to any existing or future shareholders any rights,
privileges or protections (other than to Abundant Glory, Abundant Grace or Astral Success or their respective assignees or successors)
more favorable than those offered to the Purchasers, the Purchasers shall be entitled to such rights, privileges and protections automatically.
8.2 Use
of Proceeds. The Company shall maintain a separate bank account to hold the proceeds from the Closing (the “Designated Bank
Account”, as specified in Schedule II), and the joint signatories of the Designated Bank Account shall be amended prior
to the Closing to include a representative designated by the Purchasers and the chief executive officer of the Company. Any disbursement
or withdrawal from such account shall require the signatures of a representative designated by the Purchasers and the chief executive
officer of the Company. Such disbursement or withdrawal, if any, unless otherwise agreed by the Company and the Purchasers, shall be
made at the beginning of each quarter in accordance with the Company’s annual budget to be agreed by the Purchasers.
8.3 Listing
of ADSs. The Company hereby agrees to use reasonable best efforts to maintain the listing or quotation of the ADSs on the Trading
Market on which it is currently listed.
8.4 Compliance
with Applicable Laws. The Company shall obtain consent, approval, order or authorization of, or registration or filing with, or giving
notice to, any governmental or public body or authority prior to or after the Closing if any such action is required by the Applicable
Laws.
8.5 Survival
of Representations and Covenants. The representations, warranties, covenants and agreements contained in Sections 5.1 to 5.5
(the “Company Fundamental Representations”) and 8.1 to 8.4 of this Agreement shall survive indefinitely
or until the latest date permitted by law. The other representations and warranties of the Company shall survive the Closing until the
expiration of 24 months from the Closing.
Section 9
ADDITIONAL AGREEMENTS
9.1 Indemnification.
(a) Subject to the other provisions of this Section 9, The Company (the “Indemnifying Party”) shall
indemnify and hold each Purchaser and its Affiliates, and each of their respective directors, officers, employees, advisors and agents
(each an “Indemnified Party”, and collectively, the “Indemnified Parties”) harmless from and against
any and all losses, liabilities, obligations, claims, contingencies, damages, diminution in value, costs and expenses, including all
judgements, amounts paid in settlements, court costs, reasonable attorney’s fees and expenses of other experts or advisors, and
costs of investigation (collectively, “Loss”) resulting from or arising out of: (i) any breach or violation of,
or inaccuracy in, any representation or warranty made by the Indemnifying Party or its applicable Affiliates under this Agreement or
the Transaction Documents, or (ii) any breach or violation of or failure to perform, any covenants or agreements made by or on behalf
of, or to be performed by, the Indemnifying Party or its applicable Affiliates under this Agreement or the Transaction Documents, (iii) any
Action instituted against the Indemnified Parties in any capacity by (A) any current or former shareholder of the Company who is
not an Affiliate of such Indemnified Party, with respect to any of the transactions contemplated by the Transaction Documents or (B) any
other third party with respect to any of the transactions contemplated by the Transaction Documents (unless, in either case, such Action
is based upon a breach of such Indemnified Party’s representations, warranties or covenants under the Transaction Documents or
any agreements or understandings such Indemnified Party may have with any such shareholder or any violations by such Indemnified Party
of state or federal securities laws of the United States or any conduct by such Indemnified Party which constitutes fraud, gross negligence
or willful misconduct).
(b) No
Indemnified Party shall be entitled to recover any Losses under clause (i) of Section 9.1(a), other than with respect
to breaches of the Company Fundamental Representations, until such time as the aggregate amount of all such Losses that have been suffered
or incurred by any one or more of the Indemnified Parties under clause (i) of Section 9.1(a) exceeds $112,500 (the
“Loss Threshold”), provided, however, that once the aggregate amount of all such Losses under clause (i) of Section 9.1(a) exceeds
the Loss Threshold, the Indemnifying Party shall be liable for all such Losses under clause (i) of Section 9.1(a) (including
the Loss Threshold).
(c) The
maximum aggregate amount of Losses that each Indemnified Party will be entitled to recover under clause (i) of Section 9.1(a),
other than with respect to breaches of the Company Fundamental Representations, shall be limited to the aggregate amount of the Exercise
Price paid hereunder by such Indemnified Party or its Affiliate plus an amount accruing thereon at a compound annual rate of eight percent
(8%) of the foregoing aggregate amount. Notwithstanding the foregoing or anything else to the contrary contained herein, the limitations
on indemnification set forth in this Agreement (including, without limitation, the limitations set forth in this Section 9.1)
shall not apply to any claim based on fraud or willful misconduct of the Indemnifying Party or its Subsidiaries or Affiliates.
9.2 The
Indemnifying Party shall not be liable for any Loss consisting of punitive damages (except to the extent that such punitive damages are
awarded to a third party against an Indemnified Party in connection with a third-party claim).
9.3 Solely
for the purpose of determining the amount of any Losses (and not for determining any breach) for which the Indemnified Parties may be
entitled to indemnification pursuant to this Section 9, any representation or warranty contained in this Agreement that is
qualified by a term or terms such as “material,” or “materially,” shall be deemed made or given without such
qualification and without giving effect to such words.
9.4 The
Indemnified Parties shall not be entitled to recover from the Indemnifying Party under this Agreement more than once in respect of the
same Losses suffered.
9.5 Notwithstanding
any other provision contained herein, the remedies contained in this Section 9 shall be the sole and exclusive monetary remedy
of the Indemnified Parties for any claim arising out of or resulting from this Agreement, except that no limitation or exceptions with
respect to the obligations or liabilities of the Indemnifying Party provided hereunder shall apply to a Loss incurred by any Indemnified
Party arising due to fraud of the Indemnifying Party or its Subsidiaries or Affiliates. Nothing in this Section 9 or elsewhere
in this Agreement shall affect any Parties’ rights to specific performance or other equitable or non-monetary remedies with
respect to the covenants and agreements in this Agreement or that are to be performed at or after the Closing; provided that for
the avoidance of doubt, except in the case of fraud, nothing contained herein shall permit any Party to rescind this Agreement.
Section 10
MISCELLANEOUS
10.1 Notices.
All notices, requests, waivers and other communications made pursuant to this Agreement shall be in writing and shall be conclusively
deemed to have been duly given (a) when hand delivered to the other Parties, upon delivery; (b) when sent by email at the address
set forth in Schedule III hereto; (c) ten (10) days after deposit in the mail as air mail or certified mail, receipt
requested, postage prepaid and addressed to the other Parties as set forth in Schedule III; or (d) five (5) days after
deposit with an international overnight delivery service, postage prepaid, addressed to the Parties as set forth in Schedule III
with next Business Day delivery guaranteed, provided that the sending Party receives a confirmation of delivery from the
delivery service provider. A Party may change or supplement the notice information given above, or designate additional addresses, for
purposes of this Section 10.1 by giving the other Parties written notice of the new address and/or other notice information
in the manner set forth above.
10.2 Amendments.
Any term of this Agreement may be amended only with the written consent of all of the Parties.
10.3 Entire
Agreement. This Agreement and the schedules and exhibits hereto, which are hereby expressly incorporated herein constitute the entire
understanding and agreement among the Parties with regard to the subjects hereof and supersedes any and all of the prior negotiations,
correspondence, agreements, understandings, duties or obligations among the Parties in respect of the subject matter hereof.
10.4 Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. Facsimile and e-mailed copies of signatures shall be deemed to be originals for purposes of the
effectiveness of this Agreement.
10.5 Severability.
If any provision of this Agreement is found to be invalid or unenforceable, then such provision shall be construed, to the extent feasible,
to render such provision enforceable and to provide for the consummation of the transactions contemplated hereby on substantially the
same terms as originally set forth herein, and if no feasible interpretation would save such provision, it shall be severed from the
remainder of this Agreement, which shall remain in full force and effect unless the severed provision is essential to the rights or the
benefits intended by the Parties. In such event, each Party shall use its best efforts to negotiate, in good faith, a substitute, valid
and enforceable provision or agreement which most nearly effects the Parties’ intention in entering into this Agreement.
10.6 Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any Party under this Agreement, upon any breach
or default of any other Party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting
Party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach
or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default
theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any Party of any
breach or default under this Agreement, or any waiver on the part of any Party of any provisions or conditions of this Agreement, must
be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement
or by law or otherwise afforded to any Party, shall be cumulative and not alternative.
10.7 No
Presumption. The Parties acknowledge that each Party has been represented by counsel in connection with this Agreement. Accordingly,
any rule of law or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the
Party that drafted it, has no application and is expressly waived. If any claim is made by a Party relating to any conflict, omission
or ambiguity in the provisions of this Agreement, no presumption or burden of proof or persuasion will be implied because this Agreement
was prepared by or at the request of any Party or its counsel.
10.8 Governing
Law. This Agreement shall be governed by and construed under the laws of Hong Kong, without regard to principles of conflict of laws
thereunder.
10.9 Dispute
Resolution. Any dispute arising out of or relating to this Agreement, including any question regarding its existence, validity or
termination shall be referred to and finally resolved by arbitration at the Hong Kong International Arbitration Centre (the “HKIAC”)
under the HKIAC Administered Arbitration Rules. Each of the Parties irrevocably waives, to the fullest extent it may effectively do so,
any objection which it may now or hereafter have to the laying of venue of any such arbitration, and submits to the exclusive
jurisdiction of Hong Kong in any such arbitration. There shall be three (3) arbitrators. The claimant shall appoint one (1) arbitrator,
and the respondent shall appoint one (1) arbitrator no more than ten (10) days following the official appointment of the arbitrator
appointed by the claimant, failing which such arbitrator shall be appointed by HKIAC; the third arbitrator shall be the presiding arbitrator
and shall be appointed jointly by the arbitrators ap-pointed by the claimant and respondent within ten (10) days of the later of
the appointment of the arbitrators appointed by the said Parties, failing which such arbitrator shall be appointed by HKIAC. The language
to be used in the arbitration proceedings shall be English.
10.10 Expenses.
At the Closing, the Company shall reimburse all expenses (including but not limited to legal fees, financial or other business due diligence
associated herewith) reasonably incurred by the Purchasers in connection with the transaction contemplated herein of no more than US$[***]
(the “Cap Amount”). If the Company terminates discussions related to the transactions contemplated hereunder, or the
Closing has not occurred due to any reason not attributable to the Purchasers, the Company shall still pay all the expenses reasonably
incurred by the Purchasers subject to the Cap Amount.
10.11 Termination.
This Agreement may be terminated, with respect to any Purchaser, (i) by mutual written consent of the Company and such Purchaser,
(ii) by the Company or the Purchaser, if the Closing has not been consummated by September 30, 2023, due to the reason not
attributable to the Company or the Purchaser (as applicable), (iii) by the Purchaser, by written notice to the Company if there
has been a material misrepresentation or material breach of a covenant or agreement contained in this Agreement on the part of the Company,
or (iv) by the Purchaser if, due to any change of the Applicable Laws, the consummation of the transactions contemplated hereunder
would become prohibited under Applicable Laws.
10.12 Effect
of Termination. Upon the termination of this Agreement pursuant to Section 10.11
between the Company and a Purchaser, (a) this Agreement shall become void and of no further force and effect as between the
Company and such Purchaser, except for the provisions of Sections 10.1, 10.8, 10.9, 10.10 and 10.12,
which shall survive the termination of this Agreement, and (b) without limiting the generality of item (a) of this Section 10.12,
with respect to the Warrants held by such Purchaser, the amendments to such Warrants set forth in this Agreement shall be unwound and
the terms of such Warrants shall resume to those existing prior to the date hereof.
[remainder
of this page IS intentionally LEFT blank]
IN WITNESS WHEREOF, the Parties hereto have caused
their duly authorized representatives to execute this Agreement as of the date first above written.
|
THE COMPANY: |
|
|
|
Uxin Limited |
|
|
|
|
|
By: |
/s/
Kun Dai |
|
Name: Kun Dai (戴琨) |
|
Title: Director |
SIGNATURE PAGE TO AGREEMENT
IN RELATION TO AMENDMENT TO AND EXERCISE OF WARRANTS ISSUED BY UXIN LIMITED
IN WITNESS WHEREOF, the Parties hereto have caused
their duly authorized representatives to execute this Agreement as of the date first above written.
|
THE PURCHASER: |
|
|
|
Astral Success Limited |
|
|
|
|
|
By: |
/s/
Erhai Liu |
|
Name: Erhai Liu |
|
Title: Authorized Signatory |
SIGNATURE PAGE TO AGREEMENT
IN RELATION TO AMENDMENT TO AND EXERCISE OF WARRANTS ISSUED BY UXIN LIMITED
IN WITNESS WHEREOF, the Parties hereto have caused
their duly authorized representatives to execute this Agreement as of the date first above written.
|
THE PURCHASER: |
|
|
|
Alpha Wealth Global Limited |
|
|
|
|
|
By: |
/s/
Huang Tao |
|
Name: Huang Tao |
|
Title: Director |
SIGNATURE PAGE TO AGREEMENT IN RELATION TO AMENDMENT
TO AND EXERCISE OF WARRANTS ISSUED BY UXIN LIMITED
SCHEDULE I
LIST OF PURCHASERS
Name of Purchasers | |
Number
of Warrant Shares | | |
Exercise
Price Payable | |
Astral Success Limited | |
| 218,818,380 | | |
US$ | 10,000,000 | |
Alpha Wealth Global Limited | |
| 261,810,806 | | |
US$ | 11,964,754 | |
SCHEDULE II
DESIGNATED BANK ACCOUNT
[***]
SCHEDULE III
NOTICE INFORMATION
For the purpose of the notice provisions contained in this Agreement,
the following are the initial addresses of each Party:
If to Astral Success:
|
Astral Success Limited
[***] |
|
|
If to Alpha:
|
Alpha Wealth Global Limited
[***] |
|
|
If to the Company:
|
Uxin Limited
[***] |
SCHEDULE IV
FORM OF INCUMBENCY CERTIFICATE
[***]
EXHIBIT I
FORM OF CERTIFICATE OF DESIGNATION
EXHIBIT II
FORM OF REGISTRATION RIGHTS AGREEMENT
EXHIBIT III
FORM OF VOTING AGREEMENT
EXHIBIT IV
FORM OF DILUTIVE ISSUANCE NOTICE
Uxin (NASDAQ:UXIN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Uxin (NASDAQ:UXIN)
Historical Stock Chart
From Aug 2023 to Aug 2024